ZYUS Life Sciences Corporation manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union. The company offers Trichomylin, a softgel capsules with fixed dose combination of cannabinoids formulated that is phase 2 clinical trial for the treatment of chronic pain in adults caused due to musculoskeletal injuries, arthritis, and cancer. ZYUS Life Sciences Corporation was founded in 2018 and is headquartered in Saskatoon, Canada.
Show more...
FAQ
Phoenix Canada Oil Company Limited 今天的股价是多少?▼
PHXCF 当前价格为 $0.2 USD,过去 24 小时上涨了 +0%。在图表上更密切关注 Phoenix Canada Oil Company Limited 股价表现。
Phoenix Canada Oil Company Limited 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Phoenix Canada Oil Company Limited 的股票以代码 PHXCF 进行交易。
Phoenix Canada Oil Company Limited 的市值是多少?▼
今天 Phoenix Canada Oil Company Limited 的市值为 1.06M
Phoenix Canada Oil Company Limited 上一季度的财报怎么样?▼
PHXCF 上季度财报为每股 -0.01 USD,预估为 0 USD,带来 -∞% 的意外。下季度预估财报为每股 不适用 USD。
Phoenix Canada Oil Company Limited 去年的营收是多少?▼
Phoenix Canada Oil Company Limited 去年的营收为 0USD。
Phoenix Canada Oil Company Limited 去年的净利润是多少?▼
PHXCF 去年的净收益为 -279,793.94USD。
Phoenix Canada Oil Company Limited 属于哪个行业?▼
Phoenix Canada Oil Company Limited从事于Health Care行业。
Phoenix Canada Oil Company Limited 何时完成拆股?▼
Phoenix Canada Oil Company Limited 最近没有进行任何拆股。
Phoenix Canada Oil Company Limited 的总部在哪里?▼
Phoenix Canada Oil Company Limited 的总部位于 CA 的 Saskatoon。